Comparable stake leader
Lind Partners LLC
SEC ownership of Enlivex Ltd.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001596812.
Disclosed value leader
Lind Partners LLC
Comparable rows
33/33
Latest evidence
11 Aug 2026
- Public ticker
- ENLV on Nasdaq
- Parsed ownership sources
-
13D/G, 3/4/5, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Lind Partners LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
33 of 33
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Lind Partners LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
11 Aug 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001596812
- Issuer location
- Tel Aviv
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Enlivex Ltd. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Lind Partners LLC
Disclosed value leader
Lind Partners LLC
Comparable rows
33/33
Latest evidence
11 Aug 2026
13D/G
3/4/5
13F
Lead comparable stake: 10%
13D/G row: Lind Partners LLC
Showing 1-8 of 33 holder rows.
Quick read
Lind Partners LLC leads the comparable SEC ownership view at 10%.
33 of 33 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Lind Partners LLC's linked filing trail.
Comparable ownership
Top 5
Lind Partners LLC
10%
Shai A. Novik
166%
Avraham Havron
4.4%
Oren Hershkovitz
4.1%
Einat Galamidi
3.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 33 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Lind Partners LLC |
13D/G
Lind Global Asset Management XIV, LLC
|
10%
|
$12,858,052
1,927,744 shares
|
$0 | 11 Aug 2026 |
| Shai A. Novik |
3/4/5
Director
|
166%
|
$7,252,977
6,974,017 shares
|
— | 18 Mar 2026 |
| Avraham Havron |
3/4/5
Director
|
4.4%
|
$191,189
183,836 shares
|
— | 18 Mar 2026 |
| Oren Hershkovitz |
3/4/5
Chief Executive Officer
|
4.1%
|
$179,769
172,855 shares
|
— | 18 Mar 2026 |
| Einat Galamidi |
3/4/5
Chief Medical Officer
|
3.7%
|
$162,556
156,304 shares
|
— | 18 Mar 2026 |
| Shachar Shlosberger |
3/4/5
Chief Financial Officer
|
3.3%
|
$144,886
139,314 shares
|
— | 18 Mar 2026 |
| Gili Hart |
3/4/5
Director
|
0.18%
|
$7,978
7,672 shares
|
— | 18 Mar 2026 |
| Roger Pomerantz |
3/4/5
Director
|
0.06%
|
$2,579
2,480 shares
|
— | 18 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 13 Sep 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-7 of 7 reporting-owner rows connected to Enlivex Ltd.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
7
Largest Forms 3/4/5 holder
Shai A. Novik
Net 12M change
$0
Latest report
18 Mar 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Shai A. Novik | Director | $7,252,977 | Mixed | 18 Mar 2026 | ||
| Avraham Havron | Director | $191,189 | Mixed | 18 Mar 2026 | ||
| Oren Hershkovitz | Chief Executive Officer | $179,769 | Mixed | 18 Mar 2026 | ||
| Einat Galamidi | Chief Medical Officer | $162,556 | Mixed | 18 Mar 2026 | ||
| Shachar Shlosberger | Chief Financial Officer | $144,886 | Mixed | 18 Mar 2026 | ||
| Gili Hart | Director | $7,978 | Mixed | 18 Mar 2026 | ||
| Roger Pomerantz | Director | $2,579 | Mixed | 18 Mar 2026 |
Recent insider transactions for Enlivex Ltd.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Roger Pomerantz | ENLV | Ordinary Shares, par value NIS 0.40 per share | 0 | 2,480 | 18 Mar 2026 | Direct | ||||
| Avraham Havron | ENLV | Ordinary Shares, par value NIS 0.40 per share | 0 | 183,836 | 18 Mar 2026 | Direct | ||||
| Einat Galamidi | ENLV | Ordinary Shares, par value NIS 0.40 per share | 0 | 156,304 | 18 Mar 2026 | Direct | ||||
| Gili Hart | ENLV | Ordinary Shares, par value NIS 0.40 per share | 0 | 7,672 | 18 Mar 2026 | Direct | ||||
| Oren Hershkovitz | ENLV | Ordinary Shares, par value NIS 0.40 per share | 0 | 172,855 | 18 Mar 2026 | Direct | ||||
| Shachar Shlosberger | ENLV | Ordinary Shares, par value NIS 0.40 per share | 0 | 139,314 | 18 Mar 2026 | Direct | ||||
| Shai A. Novik | ENLV | Ordinary Shares, par value NIS 0.40 per share | 0 | 6,974,017 | 18 Mar 2026 | Direct |
* marks a reported price that did not pass the local price check.